论文部分内容阅读
美国FDA称接到报告说,给已服用抗精神病药物的患者加用亚甲蓝可能出现中枢神经系统的不良反应,该反应是通过脑内的5-羟色胺(5-HT)系统产生作用的。有关这种潜在的药物相互作用,不管是在紧急时使用还是在非紧急时使用都正在补
The U.S. FDA said it received reports that it is possible that adverse reactions to the central nervous system may occur with the addition of methylene blue to patients who have taken antipsychotic drugs through a serotonin (5-HT) system in the brain. For potential drug interactions, whether in use at emergency or in non-emergency use